Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms

Digestive and Liver Disease

Volumn 37, Issue 6, 2005, Pages 446-450

  Grimaudo, S ^a   Craxi, A ^a   Gentile, S ^b   Di Paolantonio, T ^c   Vaccaro, A ^a   Venezia, G ^a   Lo Coco, L ^a   Savella, R ^c   Usticano, A ^a   Capone, F ^a   Mariani, G ^d  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NOVO NORDISK A S   (Denmark)

^d UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Activated FVII; Coagulation FVII; Liver cirrhosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; FIBRINOGEN; PROTHROMBIN;

ANALYSIS OF VARIANCE; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PROTHROMBIN TIME; STATISTICAL SIGNIFICANCE; ALLELE; BLOOD; CASE CONTROL STUDY; CLASSIFICATION; GENETICS;

ALLELES; CASE-CONTROL STUDIES; FACTOR VII; GENOTYPE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; POLYMORPHISM, GENETIC; PROTHROMBIN TIME;

EID: 26944437133     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.01.007     Document Type: Article

References (27)

1. Craxì A., Cammà C., and Giunta M. Clinical aspects of bleeding complications in cirrhotic patients. Blood Coagul Fibrinolysis 11 Suppl. 1 (2000) 75-79
2. Cordova C., Violi F., Alessandri C., Ferro D., Saliola M., Musca A., et al. Prekallikrein and Factor VII as prognostic indexes of liver failure. Am J Clin Pathol 85 (1986) 579-582
3. Violi F., Ferro D., Quintarelli C., Saliola M., Corodova C., and Balsano F. Clotting abnormalities in chronic liver disease. Dig Dis 10 (1992) 162-172
4. Violi F., Leo R., Vezza E., Basili S., Cordova C., and Balsano F. Bleeeding time in patients with cirrhosis: relation with degree of liver failure clotting abnormalities. CALC Group. Coagulation abnormalities in Cirrhosis Study Group. J Hepatol 20 (1994) 531-536
5. Basili S., Ferro D., Leo R., Juliano L., Alessandri C., Cordova C., et al. Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. J Hepatol 24 (1996) 574-580
6. Joist H.J., and Gorge J.N. Hemostatic abnormalities in liver and renal disease. In: Colman R.W., Hirsh J., Marder V., Clowes A.W., and George J.N. (Eds). Hemostasis and thrombosis (2001), Lippincott Williams & Wilkins, Philadelphia 955-973
7. Martinez J., and Barsigian C. Coagulopathy of liver failure and Vitamin K deficiency. In: Loscalzo J., and Schafer A.I. (Eds). Thrombosis and hemorrhage (1998), Williams & Wilkins, Baltimore 987-1004
8. Ratnoff O.D. Hemostatic defects in liver and biliary tract disease and disorders of Vitamin K metabolism. In: Ratnoff O.D., and Forbes C.D. (Eds). Disorders of hemostasis (1996), WB Saunders, Philadelphia 422-442
9. Butt A.K., Khan A.A., Alam A., Shah S.W., Shafqat F., and Naqvi A.B. Predicting hospital mortality in cirrhotic patients: comparison of Child and Acute Physiology, Age and Chronic Health Evaluation (APACHE III) scoring systems. Am J Gastroenterol 93 (1998) 2469-2475
10. Merkel C., Morabito A., Sacerdoti D., Bolognesi M., Angeli P., and Gatta A. Updating prognosis of cirrhosis by Cox's regression model using Child score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol 30 (1998) 276-282
11. Green F., Kelleher C., Wilkes H., Temple A., Meade T.W., and Humphries S. A common genetic polymorphism associated with lower coagulation Factor VII levels in healthy individuals. Arterioscler Thromb Vasc Biol 11 (1991) 540-546
12. Bernardi F., Marchetti G., Pinotti M., Arcieri P., Baronocini C., Papacchini M., et al. Factor VII gene polymorphisms contribute about one third of the FVII level variation in plasma. Arterioscler Thromb Vasc Biol 16 (1996) 72-76
13. Bernardi F., Arcieri P., Bertina R.M., Chiarotti F., Corral J., Pinotti M., et al. Contribution of Factor VII genotype to activated FVII levels. Differences in Genotype Frequencies between Northern and Southern European Populations. Arterioscler Thromb Vasc Biol 17 (1997) 1548-1553
14. Mariani G., Liberti L., D'Angelo T., and Lo Coco L. Factor VII activity and antigen. In: Jesperson J., Bertina R.M., and Haverkate F. (Eds). Laboratory techniques in thrombosis. A manual (1999), Kluwer Academic Publishers, Dordrecht/Boston/London 99-106
15. Marchetti G., Patracchini P., Papacchini M., Pinotti M., and Bernardi F. A polymorphism in the 5′ region of coagulation Factor VII gene (F7) due to an inserted decanucleotide. Hum Genet 90 (1993) 575-576
16. Humpries S., Temple A., Lane A., Green F., Cooper J., and Miller G. Low plasma levels of Factor VIIc and antigen are more strongly associated with the 10 base pair promoter (-323) insertion than the glutamin 353 variant. Thromb Haemost 75 (1996) 567-572
17. Terwilliger J.D., and Ott J. Handbook of human genetic linkage (1994), The John Hopkins University Press, Baltimore
18. Mammen E.F. Coagulation abnormalities in liver disease. Hematol Clin North Am 6 (1992) 1246-1257
19. Spector I., and Corn M. Laboratory tests of hemostasis: the relation to hemorrghage in liver disease. Arch Int Med 119 (1967) 577-582
20. Hallen A., and Nilsson I.M. Coagulation studies in liver disease. Thromb Diath Haemorrh 11 (1964) 51-63
21. Lechner K., Niessner H., and Thaler E. Coagulation abnormalities in liver disease. Semin Thromb Haemost 4 (1977) 40-56
22. Koller F. Theory and experience behind the use of coagulation tests in diagnosis and prognosis of liver disease. Scand J Gastroenterol 8 (1973) 51-61
23. Morrissey J.H. Activated Factor VII. In: Jesperson J., Bertina R.M., and Haverkate F. (Eds). Laboratory techniques in thrombosis. A manual (1999), Kluwer Academic Publishers, Dordrecht/Boston/London 89-97
24. Izumi S., Langley P.G., Wendon J., Ellis A.J., Pernambuco R.B., Hughes R.D., et al. Coagulation Factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 23 (1996) 1507-1511
25. Chan V., Lai C.L., and Chang T.K. Metabolism of antithrombin III in cirrhosis and carcinoma of the liver. Clin Sci 60 (1981) 681-688
26. Schipper H.G., and tenCate J.W. Antithrombin III transfusion in individuals with hepatic cirrhosis. Br J Haematol 52 (1982) 25-33
27. Lord JW, Andrus W deW. Differentiation of intrahepatic and extrahepatic jaundice. Response of the plasma prothrombin to intramuscular injection of menadione (2-methyl-1,4-naphtoquinone) as a diagnostic aid. Arch Intern Med 1941; 68:199-210.